Gene · 2271
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long survival in a patient with fumarate hydratase mutation-associated glioma. | J Neuropathol Exp Neurol | 2025 | 39279228 | PubTator, text mining | PubMed |
| Genotype Phenotype Correlation of Renal Tumors in the Cancer Genome Atlas Database. | Int J Surg Pathol | 2025 | 39034146 | PubTator, text mining | PubMed |
| Fumarate Hydratase-Deficient Abdominal Wall Leiomyoma Presenting a Decade Post-Fumarate Hydratase-Deficient Uterine Leiomyoma Excision: An Incidental or Syndromic Association? | Int J Surg Pathol | 2025 | 38847132 | PubTator, text mining | PubMed |
| Hereditary cutaneous leiomyomatosis and low-grade glioma due to a fumarate hydratase mutation. | J Eur Acad Dermatol Venereol | 2025 | 38831716 | PubTator, text mining | PubMed |
| From Data to Cure: A Comprehensive Exploration of Multi-omics Data Analysis for Targeted Therapies. | Mol Biotechnol | 2025 | 38565775 | PubTator, text mining | PubMed |
| Hereditary leiomyomatosis and renal cell cancer (HLRCC), pheochromocytoma (PCC)/paraganglioma (PGL) and germline fumarate hydratase (FH) variants. | Endocrinol Diabetes Metab Case Rep | 2024 | 39705504 | PubTator, text mining | PubMed |
| Fumarate hydratase-deficient renal cell carcinoma: A case report and review of literature. | Asian J Surg | 2024 | 39676016 | PubTator, text mining | PubMed |
| Proteomic and metabolomic profiling of aged pork loin chops reveals molecular phenotypes linked to pork tenderness. | J Anim Sci | 2024 | 39563021 | PubTator, text mining | PubMed |
| [Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: Clinicopathological Analysis of 11 Cases]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2024 | 39507957 | PubTator, text mining | PubMed |
| Complete response to fifth-line anti-PD-1 rechallenge in fumarate hydratase-mutated papillary renal cell carcinoma. | NPJ Precis Oncol | 2024 | 39496729 | PubTator, text mining | PubMed |
| Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists. | Virchows Arch | 2024 | 39287823 | PubTator, text mining | PubMed |
| Histopathologic classification and immunohistochemical features of papillary renal neoplasm with potential therapeutic targets. | J Pathol Transl Med | 2024 | 39257049 | PubTator, text mining | PubMed |
| Investigating response behavior through TF-IDF and Word2vec text analysis: A case study of PISA 2012 problem-solving process data. | Heliyon | 2024 | 39247276 | PubTator, text mining | PubMed |
| Sequential therapy for hereditary leiomyomatosis and renal cell cancer-associated renal cell carcinoma: a case report and report of a new family pedigree. | Oxf Med Case Reports | 2024 | 39184870 | PubTator, text mining | PubMed |
| Cutaneous leiomyosarcoma in a case of hereditary leiomyomatosis and renal cell carcinoma syndrome. | BMJ Case Rep | 2024 | 39179269 | PubTator, text mining | PubMed |
| Case report: response to immunotherapy and association with the fh gene in hereditary leiomyomatosis and renal cell cancer-associated renal cell cancer. | BMC Med Genomics | 2024 | 39160519 | PubTator, text mining | PubMed |
| Fumarate hydratase-deficient renal cell carcinoma: A rare case report. | Asian J Surg | 2024 | 39160124 | PubTator, text mining | PubMed |
| Immunohistochemical characteristics of uterine lipoleiomyomas. | Pathol Res Pract | 2024 | 39053134 | PubTator, text mining | PubMed |
| Genetic and Molecular Biomarkers in Aggressive Pheochromocytomas and Paragangliomas. | Int J Mol Sci | 2024 | 39000254 | PubTator, text mining | PubMed |
| Ferroptosis: a promising target for fumarate hydratase-deficient tumor therapeutics literature review. | Transl Cancer Res | 2024 | 38988939 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2271/papers?page=7